Oruka Therapeutics (ORKA) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -133.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.68% |
| Dec 31, 2025 | 93.33% |
| Sep 30, 2025 | -71,507.60% |
| Mar 31, 2022 | 66.67% |
| Dec 31, 2021 | 46.15% |
| Jun 30, 2021 | -433.33% |
| Mar 31, 2021 | -100.00% |
| Dec 31, 2020 | -550.00% |
| Sep 30, 2018 | 99.68% |
| Mar 31, 2018 | 1.36% |
| Dec 31, 2017 | 50.86% |
| Sep 30, 2017 | 63.42% |
| Jun 30, 2017 | 151.65% |
| Mar 31, 2017 | 157.82% |
| Dec 31, 2016 | 157,500.00% |
| Sep 30, 2016 | -127,300.00% |
| Jun 30, 2016 | -236,140.00% |
| Mar 31, 2016 | -260,000.00% |
| Dec 31, 2015 | 85.71% |
| Dec 31, 2014 | -250.00% |
| Dec 31, 2011 | -98.08% |